SCHEMBL8249847

SCHEMBL8249847

C=CCNC(=O)C(=O)C(CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.39
▸ DPP4 P27487 6/20 0.37
▸ DPP8 Q6V1X1 4/20 0.37
▸ DPP7 Q9UHL4 3/20 0.37
▸ DPP9 Q86TI2 3/20 0.37
▸ FAP Q12884 2/20 0.37
▸ OPRM1 P35372 2/20 0.36
▸ FKBP5 Q13451 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ F2 P00734 2/20 0.34
▸ XIAP P98170 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ STAT3 P40763 1/20 0.34
▸ OPRD1 P41143 1/20 0.33
▸ GRB2 P62993 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ PLG P00747 1/20 0.33
▸ PRSS1 P07477 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8248226 0.95 DPP4 (0.38) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8250093 0.92 NPSR1 (0.39) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8249934 0.91 NPSR1 (0.43) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL12605913 0.90 DPP4 (0.39) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8255656 0.90 NPSR1 (0.44) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8250760 0.90 NPSR1 (0.38) NPSR1OPRM1FKBP5ALDH1A1F2
SCHEMBL12600611 0.87 DPP4 (0.38) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8247918 0.87 DPP4 (0.38) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8253477 0.87 DPP4 (0.38) NPSR1DPP4DPP8DPP7DPP9
SCHEMBL8257927 0.86 F2 (0.39) NPSR1DPP4DPP8DPP7DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730142-B1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORP (US) 2011-06-29 — — EP disclosed
WO-2006130553-A2 HCV PROTEASE INHIBITORS SCHERING CORPORATION (US) 2006-12-07 — — WO disclosed
WO-2006130552-A2 METHODS OF TREATING HEPATITIS C VIRUS SCHERING CORPORATION (US) 2006-12-07 — — WO disclosed
WO-2006130628-A2 COMBINATION OF HCV PROTEASE INHIBITORS WITH A SURFACTANT SCHERING CORPORATION (US) 2006-12-07 — — WO disclosed
WO-2005085242-A1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-09-15 — — WO disclosed
Send feedback